Clinical Trial: An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors

U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07222267) titled 'An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors' on Oct. 28.

Brief Summary: The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary antitumor activity of BG-75202 (KAT6A/B inhibitor) alone and in combination with other therapies in participants with breast cancer and other advanced solid tumors.

Study Start Date: Dec., 2025

Study Type: INTERVENTIONAL

Condition: Breast Cancer Advanced Solid Tumor

Intervention: DRUG: BG-75202

Administered orally.

DRUG: CDK4 Inhibitor

Administered...